(firstQuint)Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema.

 This is an open label study.

 Initially, 5 patients with DME will receive an ITV injection of VEGF Trap into the study eye.

 Additional patients may be enrolled at the same or additional dose levels.

 Patients will be observed for six weeks following the injection for assessments of ocular and systemic safety.

.

 Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema@highlight

To assess the ocular and systemic safety and tolerability of a single intravitreal injection of VEGF Trap in patients with diabetic macular edema.

